Sanofi and Zealand Shares Drop

Sanofi and Zealand Shares Drop

Sources confirm that the U. S. setback for the diabetes drug has severely hit Sanofi and Zealand.

According to the statements released by the French Drugmaker Sanofi on Thursday, it has decided to presently withdraw its U. S. application for the diabetes treatment lixisenatide. The company officials said that they await the results of the ongoing cardiovascular patient study.

The company's above decision will delay the launch of the drug in the world's biggest market. As an immediate effect of its decision, the position of its shares in the market has fallen down by 1.6 percent. At 0720 GMT, the shares of Sanofi reported down along with a trembling position of its smaller Danish partner Zealand Pharma too, which dropped by 20 percent.

Sanofi look forward at resubmitting its application in 2015. It said that till then the cardiovascular test will be complete. The company's decision is not at all concerned with the safety issues or deficiencies in the new drug application, the officials explained.

Europe government has already approved the selling of Lixisenatide under the brand name Lyxumia. But, Sanofi awaits the full results of the evaluation of lixisenatide in acute coronary syndrome. The new drug will treat the patients with high cardiovascular risk.


FrenchTribune Specials

Heavy Milk Consumption could be Harmful for Women: Study

A study conducted by Swedish researchers has found that women who drink three or more glasses of milk per day could face twice the risk of death and heart disease. According to the study, those women who consumed milk heavily had about 44% increased risk of cancer, as compared to women who drink one or less glass of milk.

On the other...

Most Popular

Crew saves two Beached Pilot Whales at Sunbury Cove

Crew members have been able to save two pilot whales at...

Weight-loss surgery can lead to severe headaches

After weight reduction surgery, a few patients may be at...

Toyota sells partial stake in Tesla Motors

In a recent announcement, world's biggest automaker...

‘PhotoMath’ – a free mobile which can solve mathematical problems almost instant

London-based MicroBlink's 'PhotoMath' free mobile app is...

Poll

Can Greece Come out of Economic Problems: